INFLUENCE OF GADOLINIUM CHELATES ON P-31 MAGNETIC-RESONANCE SPECTROSCOPY OF THE LIVER

被引:0
|
作者
BAUER, H
NEGISHI, C
WEINMANN, HJ
机构
[1] SAITAMA MED SCH,DEPT RADIOL,MOROYAMA,SAITAMA 35004,JAPAN
[2] SCHERING AG,RES LABS,BERLIN,GERMANY
关键词
GADOLINIUM; RAT LIVER; MAGNETIC RESONANCE SPECTROSCOPY; CONTRAST MEDIA; P-31; STUDIES;
D O I
10.1097/00004424-199408000-00004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
RATIONALE AND OBJECTIVES. The potential of gadolinium compounds (Gd-ethoxybenzyl-DTPA [Gd-EOB-DTPA], gadopentetate dimeglumine [Gd-DTPA], and Gd-chloride [GdCl3]) to enhance the signals from intracellular phosphorus-31 nuclei in the liver was investigated. METHODS. After intravenous administration of Gd-EOB-DTPA, Gd-DTPA, and GdCl3 to rats, liver phosphorus metabolites (inorganic phosphate [Pi], phosphomonoester [PME], and adenosine triphosphate [ATP]) were measured by phosphorus-31 magnetic resonance spectroscopy (MRS). The dose of each compound was 0.2 mmol Gd/kg. Saline was used as a control. RESULTS. The intensities of the phosphorus metabolite signals in the liver showed only minor changes after administration of Gd-DTPA and GdCl3, but increased after Gd-EOB-DTPA. The signals of Pi and PME were enhanced more than those of ATP. The alpha peak of ATP increased by 21.7%, Pi by 61.2%, and PME by 49.2%. CONCLUSIONS. The signal intensities of the phosphorus metabolites in the liver were not influenced by GdCl3. Using Gd-DTPA, only a slight enhancement could be detected. The greatest enhancement was observed with Gd-EOB-DTPA, which has access to the phosphorus metabolites within the hepatocytes. The injection of Gd-EOB-DTPA results in better detectability of the Pi signal.
引用
收藏
页码:752 / 757
页数:6
相关论文
共 50 条
  • [31] P-31 MAGNETIC-RESONANCE SPECTROSCOPY IN THE EOSINOPHILIA-MYALGIA-SYNDROME
    CLAUW, DJ
    HEWES, B
    BLANK, CA
    NELSON, M
    KATZ, P
    RAJAN, S
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S114 - S114
  • [32] APPLICATION OF P-31 MAGNETIC-RESONANCE SPECTROSCOPY TO THE STUDY OF ATHLETIC PERFORMANCE
    MCCULLY, KK
    KENT, JA
    CHANCE, B
    SPORTS MEDICINE, 1988, 5 (05) : 312 - 321
  • [33] P-31 MAGNETIC-RESONANCE SPECTROSCOPY - A NEW RESEARCH INSTRUMENT IN UROLOGY
    POMER, S
    UROLOGE-AUSGABE A, 1989, 28 (04): : 223 - 230
  • [34] PHOSPHORUS MAGNETIC-RESONANCE SPECTROSCOPY (P-31 MRS) IN NEUROMUSCULAR DISORDERS
    ARGOV, Z
    BANK, WJ
    ANNALS OF NEUROLOGY, 1991, 30 (01) : 90 - 97
  • [35] BRAIN METABOLISM IN HYPOTHYROIDISM STUDIED WITH P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    SMITH, CD
    AIN, KB
    LANCET, 1995, 345 (8950): : 619 - 620
  • [36] P-31 MAGNETIC-RESONANCE SPECTROSCOPY (MRS) OF EXPERIMENTAL ORBITAL MYOSITIS
    WINGUTH, S
    KURHANEWICZ, J
    WANG, ML
    QUIVEY, JM
    JAMES, TL
    CHAR, DH
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (08) : 2417 - 2422
  • [37] ASSESSMENT OF CLINICAL RENAL PRESERVATION BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    BRETAN, PN
    VIGNERON, DB
    HRICAK, H
    PRICE, D
    JAMES, TL
    JOURNAL OF UROLOGY, 1986, 135 (04): : A206 - A206
  • [38] RESPONSE OF TUMORS TO THERAPY STUDIED BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    KARCZMAR, GS
    MEYERHOFF, DJ
    SPEDER, A
    VALONE, F
    WILKINSON, M
    SHINE, N
    BOSKA, MD
    WEINER, MW
    INVESTIGATIVE RADIOLOGY, 1989, 24 (12) : 1020 - 1023
  • [39] P-31 MAGNETIC-RESONANCE SPECTROSCOPY AND VENTRICULAR ENLARGEMENT IN BIPOLAR DISORDER
    KATO, T
    SHIOIRI, T
    MURASHITA, J
    HAMAKAWA, H
    INUBUSHI, T
    TAKAHASHI, S
    PSYCHIATRY RESEARCH-NEUROIMAGING, 1994, 55 (01) : 41 - 50
  • [40] MAGNETIC-RESONANCE IMAGING AND P-31 MAGNETIC-RESONANCE SPECTROSCOPY FOR EVALUATING FOCAL CEREBRAL-ISCHEMIA
    GERMANO, IM
    PITTS, LH
    BERRY, I
    MOSELEY, M
    JOURNAL OF NEUROSURGERY, 1989, 70 (04) : 612 - 618